Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Security class unavailable · CUSIP: 38000Q102
Event date: 2019-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,768,257
- Percent of class
- 11.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-19-000279
- Form type
- SC 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Jun 10, 2019
- Reporting period
- May 31, 2019
- Description
- Schedule 13G beneficial ownership